This finding aligns with the results of another study on TOLLIP in IPF, where the T/C genotype was associated to a significantly shorter time to disease progression compared to the T/T genotype (43.5 vs. 63 months) (12). This evidence concerns the gene TOLLIP and idiopathic pulmonary fibrosis.